NarendranathEpperlaMDMS

PubMed

• Response to: Correspondence on 'Cardiovascular toxicities associated with bispecific T-cell engager therapy' by Noguchi.
  Ahmed Sayed, Malak Munir, Michael Poliner, Sana Sughra, Narendranath Epperla, Daniel Addison> ;Journal for Immunotherapy of Cancer. 2024 Apr 22
• Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T.
  Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Brian T...> ;Blood Advances. 2024 Mar 26
• Post-infusion PD-1+CD8+CAR-T cells identify patients responsive to CD19-CAR-T therapy in non-Hodgkin's lymphoma.
  Voorhees, T. J., Nathan Denlinger, No-Joon Song, Xiaoli Zhang, Hyeongseon Jeon, Chelsea Peterson, Yi Wang, Kelsi Reynolds, Robert Bolz, Jessica Miao, Chunhua Song, Day...> ;Blood Advances. 2024 Mar 23
• Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy.
  Megan Melody, Narendranath Epperla, Geoffrey Shouse, Jason T Romancik, Pamela Blair Allen, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Lindsey A Fitzgerald, Br...> ;Blood Advances. 2024 Mar 18
• 3 citations
  Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5).
  Epperla, N., Sattva S Neelapu, Julio C Chavez, Alison R Sehgal, Narendranath Epperla, Matthew Ulrickson, Emmanuel Bachy, Pashna N Munshi, Carla Casulo, David G Maloney...> ;Blood. 2024 Feb 8
• 1 citations
  Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.
  Steiner, R., Hwang, S., Khurana, A., Habermann, T., Epperla, N., Annunzio, K., Allen, P., Baird, K., Paulino, D., Alderuccio, J., Lossos, I., David, K., Evens, A., Pan...> ;Blood Advances. 2023 Dec 26
• Another step toward frontline BTK inhibitor therapy in MCL.
  Hanel, W., Epperla, N.> ;Blood Advances. 2023 Dec 12
• Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.
  Madiha Iqbal, Deepa Jagadeesh, Julio Chavez, Arushi Khurana, Allison Rosenthal, Emily Craver, Narendranath Epperla, Zhuo Li, Iris Isufi, Farrukh T Awan, Bhagirathbhai ...> ;Bone Marrow Transplantation. 2024 Feb 1
• 4 citations
  High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
  Zayac, A., Landsburg, D., Hughes, M., Bock, A., Nowakowski, G., Ayers, E., Girton, M., Hu, M., Beckman, A., Li, S., Medeiros, L., Chang, J., Stepanovic, A., Kurt, H., ...> ;Blood Advances. 2023 Nov 14
• Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
  Narendranath Epperla, Lei Feng, Nirav N Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M Stephens, Catherine J Lee, Thomas Ollila, Geoffrey Shouse, Alexey V Danilov, Ke...> ;Journal of Hematology & Oncology. 2023 Nov 9
• Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
  Barr, P. M., Barr, P. M., Barr, P. M., Karmali, R., Alexandra Rezazadeh, Aniko Szabo, Arushi Khurana, David J Inwards, Matthew A Lunning, Nancy L Bartlett, Paolo F Cai...> ;Haematologica. 2023 Oct 19
• Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.
  Kaitlin Annunzio, Natalie S Grover, Rina Li Welkie, Pallawi Torka, Marcus P Watkins, Andrea Anampa-Guzmán, Montreh Tavakkoli, Timothy S Oh, Heather Reves, Daniel Jones...> ;Blood Advances. 2023 Nov 28
• Survival of patients with transformed follicular lymphoma in the United States: a multiple cohort study.
  Narendranath Epperla, Vaughn, J. L., John L Vaughn> ;Biomarker Research. 2023 Sep 27
• Impact of circulating lymphoma cells at diagnosis on outcomes in patients with Waldenstrom macroglobulinemia.
  Ansel Nalin, Qiuhong Zhao, Timothy Voorhees, David Bond, Yazeed Sawalha, Walter Hanel, Audrey Sigmund, Kaitlin Annunzio, Lapo Alinari, Robert Baiocchi, Kami Maddocks, ...> ;Frontiers in Oncology. 2023 Jan 1
• 2 citations
  ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
  Zurko, J. C., Rezvani, A. R., Narendranath Epperla, Ambuj Kumar, Syed A Abutalib, Farrukh T Awan, Yi-Bin Chen, Ajay K Gopal, Jennifer Holter-Chakrabarty, Natasha Kekre...> ;Transplantation and Cellular Therapy. 2023 Sep 1
• 1 citations
  Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents.
  Neeraj Jain, Mukesh Mamgain, Sayan Mullick Chowdhury, Udita Jindal, Isha Sharma, Lalit Sehgal, Narendranath Epperla> ;Journal of Hematology & Oncology. 2023 Aug 25
• 2 citations
  Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.
  Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, Krysta Mila Coyle, Laura K Hilton, Evangelia Chavdoula, Parvathi Ranganathan, Neeraj Jain, Walter Hanel, Philip ...> ;Leukemia. 2023 Oct 1
• Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.
  Jackson T Bowers, Jacob Anna, Steven M Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A Spinner, Shuning Li, Marcus R Mess...> ;Blood Advances. 2023 Nov 14
• 3 citations
  Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study.
  Narendranath Epperla, Qiuhong Zhao, Reem Karmali, Pallawi Torka, Lauren Shea, Timothy S Oh, Andrea Anampa-Guzmán, Heather Reves, Montreh Tavakkoli, Irl Brian Greenwell...> ;Blood Advances. 2023 Sep 12
• 8 citations
  Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
  Major, A., Major, A., Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Samuel Singer, Mary-Kate Malecek, Jordan Carter, Adam Zayac, Myung Sun Kim, ...> ;American Journal of Hematology. 2023 Jun 1
• 6 citations
  Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.
  Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali, Lauren Shea, Andrea Anampa-Guzmán, Timothy S Oh, Heather Reaves, Montreh Tavakkoli,...> ;Journal of Hematology & Oncology. 2023 May 8
• 4 citations
  Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
  Marshall McKenna, Narendranath Epperla, Armin Ghobadi, Jieqi Liu, Aleksandr Lazaryan, Uroosa Ibrahim, Caron A Jacobson, Seema G Naik, Loretta Nastoupil, Sayan Mullick ...> ;British Journal of Haematology. 2023 Jul 1
• EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
  Agrawal P, David KA, Chen Z, Sundaram S, Kim SH, Vaca R, Lin Y, Singer S, Malecek MK, Carter J, Zayac A, Kim MS, Reddy N, Ney D, Habib A, Strouse C, Graber J, Bachanov...> ;Leukemia & lymphoma. 2023-03-24
• 4 citations
  A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
  Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, ...> ;Cancers. 2023 Feb 24
• 1 citations
  Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
  Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S Blachly, Kerry A Rogers, Gerard Lozanski, Christopher C Oakes, Seema A Bhat, Clive S Zent, ...> ;American Journal of Hematology. 2023 May 1
• Join now to see all

Abstracts/Posters

• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Narendranath Epperla, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019